211 related articles for article (PubMed ID: 23333597)
1. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
Li L; Yang G; Ren C; Tanimoto R; Hirayama T; Wang J; Hawke D; Kim SM; Lee JS; Goltsov AA; Park S; Ittmann MM; Troncoso P; Thompson TC
Mol Oncol; 2013 Jun; 7(3):484-96. PubMed ID: 23333597
[TBL] [Abstract][Full Text] [Related]
2. Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer.
Karantanos T; Tanimoto R; Edamura K; Hirayama T; Yang G; Golstov AA; Wang J; Kurosaka S; Park S; Thompson TC
Int J Cancer; 2014 Apr; 134(8):2003-13. PubMed ID: 24590455
[TBL] [Abstract][Full Text] [Related]
3. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
4. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
5. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
Li L; Ren C; Yang G; Fattah EA; Goltsov AA; Kim SM; Lee JS; Park S; Demayo FJ; Ittmann MM; Troncoso P; Thompson TC
Cancer Res; 2011 Dec; 71(24):7694-704. PubMed ID: 22025562
[TBL] [Abstract][Full Text] [Related]
6. AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation.
Asteriti IA; Polverino F; Stagni V; Sterbini V; Ascanelli C; Naso FD; Mastrangelo A; Rosa A; Paiardini A; Lindon C; Guarguaglini G
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36797043
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.
Janeček M; Rossmann M; Sharma P; Emery A; Huggins DJ; Stockwell SR; Stokes JE; Tan YS; Almeida EG; Hardwick B; Narvaez AJ; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
Sci Rep; 2016 Jun; 6():28528. PubMed ID: 27339427
[TBL] [Abstract][Full Text] [Related]
8. AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway.
Naso FD; Polverino F; Cilluffo D; Latini L; Stagni V; Asteriti IA; Rosa A; Soddu S; Guarguaglini G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167116. PubMed ID: 38447882
[TBL] [Abstract][Full Text] [Related]
9. Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.
Lee SY; Kim EY; Kim KH; Lee KA
Cell Cycle; 2016 Dec; 15(23):3296-3305. PubMed ID: 27753540
[TBL] [Abstract][Full Text] [Related]
10. GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
Karanika S; Karantanos T; Kurosaka S; Wang J; Hirayama T; Yang G; Park S; Golstov AA; Tanimoto R; Li L; Thompson TC
Mol Cancer; 2015 Jun; 14():122. PubMed ID: 26084402
[TBL] [Abstract][Full Text] [Related]
11. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y
Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334
[TBL] [Abstract][Full Text] [Related]
12. Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.
Orth M; Unger K; Schoetz U; Belka C; Lauber K
Oncogene; 2018 Jan; 37(1):52-62. PubMed ID: 28869599
[TBL] [Abstract][Full Text] [Related]
13. Aurora A phosphorylation of WD40-repeat protein 62 in mitotic spindle regulation.
Lim NR; Yeap YY; Ang CS; Williamson NA; Bogoyevitch MA; Quinn LM; Ng DC
Cell Cycle; 2016; 15(3):413-24. PubMed ID: 26713495
[TBL] [Abstract][Full Text] [Related]
14. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
[TBL] [Abstract][Full Text] [Related]
15. A functional interplay between Aurora-A, Plk1 and TPX2 at spindle poles: Plk1 controls centrosomal localization of Aurora-A and TPX2 spindle association.
De Luca M; Lavia P; Guarguaglini G
Cell Cycle; 2006 Feb; 5(3):296-303. PubMed ID: 16418575
[TBL] [Abstract][Full Text] [Related]
16. TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.
van Gijn SE; Wierenga E; van den Tempel N; Kok YP; Heijink AM; Spierings DCJ; Foijer F; van Vugt MATM; Fehrmann RSN
Oncogene; 2019 Feb; 38(6):852-867. PubMed ID: 30177840
[TBL] [Abstract][Full Text] [Related]
17. WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.
Zhou Q; Chen X; He H; Peng S; Zhang Y; Zhang J; Cheng L; Liu S; Huang M; Xie R; Lin T; Huang J
Theranostics; 2021; 11(10):4809-4824. PubMed ID: 33754029
[No Abstract] [Full Text] [Related]
18. CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.
Li H; Wang Y; Lin K; Venkadakrishnan VB; Bakht M; Shi W; Meng C; Zhang J; Tremble K; Liang X; Song JH; Feng X; Van V; Deng P; Burks JK; Aparicio A; Keyomarsi K; Chen J; Lu Y; Beltran H; Zhao D
Cancer Res; 2022 Sep; 82(17):3088-3101. PubMed ID: 35771632
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma.
Du R; Li K; Zhou Z; Huang Y; Guo K; Zhang H; Chen Z; Zhao X; Han L; Bian H
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083097
[TBL] [Abstract][Full Text] [Related]
20. High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.
Vainio P; Mpindi JP; Kohonen P; Fey V; Mirtti T; Alanen KA; Perälä M; Kallioniemi O; Iljin K
PLoS One; 2012; 7(6):e39801. PubMed ID: 22761906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]